Daré Bioscience receives $1.5 million grant installment for contraceptive development
DARE•Daré Bioscience received a $1.5 million grant installment for preclinical development of contraceptive DARE-LARC1, bringing total non-dilutive funding to approximately $43.3 million. About $5.6 million remains under a grant commitment of up to approximately $48.9 million, subject to milestones and other requirements.
1. Grant funding
Daré Bioscience received a $1.5 million grant installment for preclinical development of DARE-LARC1. The installment brings total non-dilutive funding to approximately $43.3 million; about $5.6 million remains under the grant commitment of up to approximately $48.9 million, subject to milestones and other requirements.
